Clinical Trial: A Prospective, Open-Label, Proof-of-Concept Human Intervention Study to Evaluate the Effects of Aspartame on Gut Microbiota and Metabolites in Healthy Adults (China)

China, Aug. 18 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A Prospective, Open-Label, Proof-of-Concept Human Intervention Study to Evaluate the Effects of Aspartame on Gut Microbiota and Metabolites in Healthy Adults'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600130205

Registration Time: 2026/08/17

Type: Interventional study

Primary Sponsor: Shanghai Institute of Nutrition and Health, Chinese Academy of Sciences

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=333790

Published by HT Digital Content Services with permission from Health Daily Digest....